CollPlant Biotechnologies (CLGN) Total Liabilities (2017 - 2026)

CollPlant Biotechnologies has reported Total Liabilities for 10 years, with the latest figure at $4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 10.68% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (down 10.68% YoY), and the FY2025 full-year result was $4.7 million, down 10.31% from the prior year.
• Total Liabilities for Q1 2026 stood at $4.3 million, down from $4.7 million in the prior quarter.
• The five-year high for Total Liabilities was $5.9 million in Q1 2023, with the low at $4.3 million in Q1 2026.
• Historically, Total Liabilities has averaged $5.2 million across 5 years, with a median of $5.2 million in 2024.
• Annual changes were most pronounced in 2023 — Total Liabilities advanced 12.67% — and 2025, when it fell 17.7%.
• CollPlant Biotechnologies' Total Liabilities stood at $5.5 million in 2022, then climbed by 5.45% to $5.8 million in 2023, then dropped by 9.35% to $5.2 million in 2024, then dropped by 10.31% to $4.7 million in 2025, then declined by 8.65% to $4.3 million in 2026.
• The last three Total Liabilities figures came in at $4.3 million (Q1 2026), $4.7 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.